Search

Search Constraints

You searched for: Author/Creator Groen, E.

Search Results

2. Morphometric analysis of ductal carcinoma in situ identifies features associated with low risk of progression to invasive breast cancer. (November 2022)

3. Omitting sentinel lymph node biopsy after neoadjuvant systemic therapy in selected breast cancer patients with clinical node-negative disease. (April 2018)

4. Risk of subsequent in situ and invasive lesions after a primary diagnosis of ductal carcinoma in situ with follow-up time up to 28 years. (October 2020)